Moderna | MRNA - Interest Expense On Debt

Stock Price
42.21
Daily Change
-0.34 -0.80%
Monthly
31.21%
Yearly
23.53%
Q1 Forecast
42.71

Moderna reported $12.14B in Interest Expense on Debt for its fiscal quarter ending in September of 2025.





Interest Expense On Debt Change Date
Acadia Pharmaceuticals USD 0 4.12M Sep/2024
Agios Pharmaceuticals USD 1.39B 85.53M Sep/2025
Alnylam Pharmaceuticals USD 44.4M 4.15M Sep/2025
Amgen USD 685M 9M Sep/2025
Arrowhead Research USD 21.69M 2.69M Sep/2025
Biogen USD 72.6M 12.6M Jun/2025
BioMarin Pharmaceutical USD 2.58M 100K Sep/2025
Celltrion KRW 19B 1.96B Jun/2025
Cspc Pharmaceutical CNY 10.19M 4.73M Sep/2025
Dianthus Therapeutics USD 4.44M 263K Sep/2024
Divis Laboratories Ltd INR 30M 20M Jun/2025
Gilead Sciences USD 254M 6M Jun/2025
GlaxoSmithKline GBP 167M 17M Sep/2025
Incyte USD 592K 2K Sep/2025
Ionis Pharmaceuticals USD 18M 1000K Sep/2025
Kangmei Pharma CNY 1.82M 150K Sep/2025
Knight Therapeutics CAD 2.37M 6K Sep/2025
Laboratorios Farma EUR 699K 666.2K Jun/2025
Moderna USD 12.14B 12.13B Sep/2025
Pharma Mar EUR 117K 1.24M Sep/2025
Qiagen NV USD 8.22M 615K Sep/2025
Regeneron Pharmaceuticals USD 12.2M 7.1M Dec/2025
Sarepta Therapeutics USD 7.56M 2.33M Sep/2025
Sartorius EUR 49.5M 8.1M Sep/2025
Sino Biopharmaceutical CNY 76.87M 114.23M Jun/2024
Tilray USD 6.7M 2.73M Jun/2025
Ultragenyx Pharmaceutical USD 14.15M 108K Sep/2025
United Therapeutics USD 3M 4.3M Sep/2025
Vertex Pharmaceuticals USD 3.3M 400K Sep/2025
Zz Pientze Pharmaceu CNY 46.05M 36.5M Jun/2025